benjamin philip levy, md, regarding combo chemotherapy & immunotherapy in 2nd line nsclc
Published 6 years ago • 22 plays • Length 1:27
Download video MP4
Download video MP3
Similar videos
-
1:38
benjamin philip levy, md, on options for nsclc patients who progress on 1st line i-o & chemotherapy
-
1:19
benjamin philip levy, md, on maintenance therapy following carboplatin, pemetrexed & pembrolizumab
-
1:20
benjamin philip levy, md, on tumor mutation burden (tmb) as a biomarker in nsclc
-
1:40
benjamin philip levy, md, offers opinion on testing for pdl-1 expression in nsclc
-
7:54
lung cancer video library 2020 - levy - immunotherapy combinations for advanced nsclc
-
1:14
dr. levy on investigational biomarkers of response to immunotherapy in nsclc
-
6:40
chemotherapy/immunotherapy combinations in lung cancer
-
4:37
dr. ben levy: the mission is to lead
-
1:12
benjamin p. levy, md discusses the importance of the chemotherapy foundation symposium
-
0:48
chemotherapy-free immunotherapy-based treatment approaches for nsclc
-
1:59
dr. levy on the role of chemotherapy in the treatment of lung cancer
-
1:15
benjamin levy on advances in diagnosing lung cancer
-
1:16
dr. levy on positive and negative biomarkers for immunotherapy in lung cancer
-
6:21
lung cancer video library 2020 - levy - immunotherapy in patients with driver mutations
-
6:57
lung cancer video library - chemo immuno therapy combinations in advanced nsclc
-
0:18
roy s. herbst, md, phd, on pemextrexed maintenance treatment
-
2:04
dr. levy on biomarkers of response to immunotherapy
-
7:16
benjamin p. levy, md: next generation sequencing in lung cancer
-
1:00
benjamin paz, md, regarding the coordination of surgical cancer services
Clip.africa.com - Privacy-policy